These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11964960)

  • 1. Autoimmune enteropathy in a child: response to infliximab therapy.
    Vanderhoof JA; Young RJ
    J Pediatr Gastroenterol Nutr; 2002 Mar; 34(3):312-6. PubMed ID: 11964960
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of severe refractory adult autoimmune enteropathy with infliximab and tacrolimus.
    von Hahn T; Stopik D; Koch M; Wiedenmann B; Dignass A
    Digestion; 2005; 71(3):141-4. PubMed ID: 15785040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pediatric autoimmune enteropathy with tacrolimus (FK506).
    Bousvaros A; Leichtner AM; Book L; Shigeoka A; Bilodeau J; Semeao E; Ruchelli E; Mulberg AE
    Gastroenterology; 1996 Jul; 111(1):237-43. PubMed ID: 8698205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult-onset autoimmune enteropathy in the setting of thymoma successfully treated with infliximab.
    Elwing JE; Clouse RE
    Dig Dis Sci; 2005 May; 50(5):928-32. PubMed ID: 15906770
    [No Abstract]   [Full Text] [Related]  

  • 5. Adult autoimmune enteropathy treated successfully with tacrolimus.
    Daum S; Sahin E; Jansen A; Heine B; Riecken EO; Zeitz M; Schmidt W
    Digestion; 2003; 68(2-3):86-90. PubMed ID: 14581765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
    Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
    J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission of severe autoimmune enteropathy after treatment with high-dose cyclophosphamide.
    Oliva-Hemker MM; Loeb DM; Abraham SC; Lederman HM
    J Pediatr Gastroenterol Nutr; 2003 May; 36(5):639-43. PubMed ID: 12717089
    [No Abstract]   [Full Text] [Related]  

  • 8. Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis.
    Farkas K; Molnár T; Szepes Z
    Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):695-702. PubMed ID: 24738535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the importance of infliximab and cyclosporine in the treatment of corticosteroid-refractory severe ulcerative colitis?
    Bengi G; Akpinar H
    Turk J Gastroenterol; 2012; 23 Suppl 2():7-12. PubMed ID: 23576083
    [No Abstract]   [Full Text] [Related]  

  • 10. Advances in Pediatric Inflammatory Bowel Disease.
    Maxwell EC; Grossman AB
    Adolesc Med State Art Rev; 2016; 27(1):57-74. PubMed ID: 27363233
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoimmune enteropathy in a pediatric patient: partial response to tacrolimus therapy.
    Steffen R; Wyllie R; Kay M; Kyllonen K; Gramlich T; Petras R
    Clin Pediatr (Phila); 1997 May; 36(5):295-9. PubMed ID: 9152557
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of infliximab-daclizumab combination for the treatment of acute and chronic graft-versus-host disease of the liver and gut.
    Rodriguez V; Anderson PM; Trotz BA; Arndt CA; Allen JA; Khan SP
    Pediatr Blood Cancer; 2007 Aug; 49(2):212-5. PubMed ID: 16261610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Outcomes and Predictors of Sustained Response in Patients with Intestinal Behcet's Disease Treated with Infliximab.
    Zou J; Ji DN; Cai JF; Guan JL; Bao ZJ
    Dig Dis Sci; 2017 Feb; 62(2):441-447. PubMed ID: 28044230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: the optimal medical management of acute severe ulcerative colitis.
    Hart AL; Ng SC
    Aliment Pharmacol Ther; 2010 Sep; 32(5):615-27. PubMed ID: 20626381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with tacrolimus and betamethasone for a patient with X-linked auto-immune enteropathy.
    Kobayashi I; Nakanishi M; Okano M; Sakiyama Y; Matsumoto S
    Eur J Pediatr; 1995 Jul; 154(7):594-5. PubMed ID: 7556338
    [No Abstract]   [Full Text] [Related]  

  • 16. Can we alter the natural history of Crohn disease in children?
    Hyams JS; Markowitz JF
    J Pediatr Gastroenterol Nutr; 2005 Mar; 40(3):262-72. PubMed ID: 15735477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of chronic inflammatory bowel diseases].
    Stange EF
    Praxis (Bern 1994); 2002 Nov; 91(47):2029-39. PubMed ID: 12501498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent drug-induced ANCA vasculitis in a patient with Crohn's colitis treated with infliximab: a potential contraindication to immunosuppressive therapy.
    Rosen DR; Cologne KG; Popek SM; Sung BC; Ortega AE; Senagore AJ
    Am Surg; 2012 Dec; 78(12):1406-8. PubMed ID: 23265134
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to autoimmune enteropathy to cyclosporin A therapy.
    Sanderson IR; Phillips AD; Spencer J; Walker-Smith JA
    Gut; 1991 Nov; 32(11):1421-5. PubMed ID: 1752480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe polyneuropathy complicating active Crohn's disease: rapid response to Infliximab.
    Rodinò S; Saccà N; D'Amico T; Fragomeni A; Giglio A
    Gut; 2003 Jul; 52(7):1070. PubMed ID: 12801971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.